Maimonides Medical Center

Maimonides Medical Center was paid $260.81M by Medicaid between Jan 2018 and Dec 2024, across 767 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 9.5% of everything it billed.

33Billing provider infoMAIMONIDES MEDICAL CENTER
BROOKLYN, NY 11219

33aNPI1093777492assigned 04/03/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$260.81M

24GClaims3,389,055

24DCodes billed767

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#5 of 231

Median peer was paid$561K

This provider vs. median465×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	24,962	$1.23M
2019	242,965	$14.42M
2020	517,183	$35.53M
2021	680,152	$46.30M
2022	653,972	$68.37M
2023	714,059	$59.71M
2024incomplete	555,762	$35.25M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	9.5%	173,713	144,495	$24.76M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	8.3%	150,495	134,651	$21.76M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.4%	73,978	68,586	$16.59M
J9271	Injection, pembrolizumab, 1 mg	4.8%	1,361	1,063	$12.56M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	4.0%	54,511	49,951	$10.53M
90834	Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient	4.0%	45,513	29,693	$10.33M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.7%	42,965	36,250	$7.04M
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	2.7%	40,111	27,348	$6.99M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	1.9%	26,777	24,254	$4.84M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.4%	15,727	15,090	$3.67M
36415	Collection of venous blood by venipuncture	1.3%	125,665	89,696	$3.51M
96361	Intravenous infusion, hydration; each additional hour	1.1%	14,336	12,413	$2.98M

755 more codes

99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.1%	28,703	$2.96M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.1%	16,975	$2.76M
99204	Doctor's office visit, new patient (more involved)	1.0%	15,459	$2.72M
80048	Basic metabolic panel (calcium, ionized)	<1%	78,966	$2.45M
G0378	Hospital observation service, per hour	<1%	3,649	$2.40M
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	908	$2.31M
19083		<1%	1,393	$2.31M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	18,290	$2.28M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	12,346	$2.25M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	25,237	$2.22M
77412		<1%	7,197	$2.08M
90853	Group psychotherapy (other than of a multiple-family group)	<1%	18,975	$2.02M
J0897	Injection, denosumab, 1 mg	<1%	1,079	$1.91M
93320		<1%	6,894	$1.89M
99203	Doctor's office visit, new patient (routine)	<1%	10,599	$1.80M
47562		<1%	661	$1.79M
59025	Fetal non-stress test	<1%	8,873	$1.72M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	13,375	$1.71M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	14,589	$1.71M
J9306	Injection, pertuzumab, 1 mg	<1%	372	$1.65M
54161		<1%	1,232	$1.65M
80053	Comprehensive metabolic panel	<1%	65,073	$1.62M
70450	Computed tomography, head or brain; without contrast material	<1%	8,081	$1.57M
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	2,073	$1.51M
90791	Psychiatric diagnostic evaluation	<1%	5,381	$1.46M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	5,929	$1.43M
96415		<1%	5,441	$1.42M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,706	$1.40M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,827	$1.35M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	329	$1.34M
90792	Psychiatric diagnostic evaluation with medical services	<1%	6,238	$1.30M
78815	Positron emission tomography (PET) for limited area imaging	<1%	2,253	$1.22M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	6,410	$1.21M
92551		<1%	18,950	$1.14M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	8,911	$1.11M
76641		<1%	21,219	$1.07M
81025		<1%	24,548	$1.05M
50590		<1%	407	$1.00M
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	583	$972K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,064	$938K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	10,224	$934K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	10,269	$926K
41899	Unlisted procedure, dentoalveolar structures	<1%	588	$921K
J2505	Injection, pegfilgrastim, 6 mg	<1%	292	$921K
99205	Prolong outpt/office vis	<1%	4,518	$915K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	843	$905K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	14,745	$904K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	3,772	$811K
77336		<1%	2,579	$778K
77049		<1%	2,166	$751K
87581		<1%	22,718	$713K
77066	Tomosynthesis, mammo	<1%	7,083	$704K
86850		<1%	21,452	$696K
93304		<1%	2,331	$683K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,132	$674K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	2,552	$672K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	7,882	$671K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	16,715	$664K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,687	$663K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	34,879	$656K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	658	$633K
76770		<1%	2,523	$631K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	11,449	$626K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	14,738	$605K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,957	$604K
12011		<1%	1,642	$597K
T1013	Sign language or oral interpretive services, per 15 minutes	<1%	16,723	$592K
D9223	Deep sedation/general anesthesia - each subsequent 15 minute increment	<1%	1,270	$583K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	6,319	$573K
44970		<1%	237	$561K
12001		<1%	1,517	$560K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	351	$549K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	20,910	$544K
87631		<1%	5,754	$534K
82803		<1%	32,477	$532K
77065	Tomosynthesis, mammo	<1%	6,397	$515K
77062		<1%	6,048	$507K
95117		<1%	7,855	$497K
D0120	Dental checkup, returning patient	<1%	17,458	$487K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	821	$486K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	3,004	$481K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	5,378	$461K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	585	$444K
Q5114	Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg	<1%	242	$441K
49505		<1%	191	$439K
10E0XZZ		<1%	1,193	$438K
88307		<1%	1,786	$434K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	5,230	$431K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	11,581	$430K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	4,133	$419K
90461		<1%	10,276	$419K
80076		<1%	47,856	$417K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	24,626	$414K
93308		<1%	1,824	$410K
94010		<1%	6,370	$403K
95782		<1%	433	$402K
93325		<1%	10,022	$401K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,834	$396K
D1120	Dental cleaning, child	<1%	11,035	$383K
93880		<1%	1,224	$380K
19301		<1%	158	$370K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	224	$366K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	1,785	$355K
90686		<1%	24,089	$351K
G0008	Administration of influenza virus vaccine	<1%	19,422	$337K
93458		<1%	198	$334K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,563	$320K
96161		<1%	7,463	$308K
76825		<1%	1,580	$301K
82962		<1%	34,148	$300K
96367		<1%	3,926	$298K
76642		<1%	6,781	$297K
86901		<1%	21,469	$292K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	2,044	$291K
99173		<1%	15,973	$286K
19081		<1%	167	$286K
83880		<1%	6,210	$285K
95115		<1%	4,065	$280K
77061		<1%	4,181	$278K
88342		<1%	2,709	$276K
D7140	Extraction, erupted tooth or exposed root	<1%	4,931	$273K
96375	Therapeutic injection; each additional sequential IV push	<1%	20,547	$267K
96416		<1%	1,064	$264K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	2,395	$263K
J1453	Injection, fosaprepitant, 1 mg	<1%	2,211	$263K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	5,342	$258K
86769		<1%	10,659	$248K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,441	$247K
77386		<1%	660	$247K
72197		<1%	761	$244K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	14,735	$233K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	6,364	$231K
86900		<1%	21,751	$230K
51798		<1%	900	$227K
87632		<1%	3,453	$224K
77387		<1%	1,160	$222K
12002		<1%	577	$215K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	11,714	$213K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	1,158	$210K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,516	$208K
D8670	Periodic orthodontic treatment visit	<1%	1,083	$206K
J9035	Injection, bevacizumab, 10 mg	<1%	68	$205K
86480		<1%	3,391	$205K
93970		<1%	566	$205K
77063	Screening digital breast tomosynthesis, bilateral	<1%	10,251	$204K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,007	$202K
90472	Immunization administration, each additional vaccine (list separately)	<1%	6,121	$202K
36430		<1%	1,613	$201K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	2,869	$199K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	57	$196K
88341		<1%	1,415	$195K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	80,849	$194K
90836		<1%	1,559	$190K
77290		<1%	568	$190K
93454		<1%	129	$189K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	3,484	$187K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	3,488	$186K
95811		<1%	243	$185K
D1110	Prophylaxis - adult	<1%	4,563	$180K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	1,299	$177K
87486		<1%	23,913	$173K
58558		<1%	121	$172K
90750		<1%	1,128	$168K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,413	$165K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	5,752	$165K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,734	$165K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,953	$162K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	12,637	$161K
96127		<1%	18,380	$160K
80061	Lipid panel	<1%	17,376	$157K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,562	$157K
96417		<1%	3,101	$156K
D1208	Topical application of fluoride, excluding varnish	<1%	12,804	$155K
71250		<1%	1,618	$155K
90715		<1%	7,376	$150K
71046	Radiologic examination, chest; 2 views	<1%	20,515	$148K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,172	$146K
77001		<1%	277	$145K
74183		<1%	435	$142K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	6,966	$141K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	13,993	$140K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	53,072	$139K
42830		<1%	64	$138K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	1,733	$137K
85610		<1%	32,671	$136K
93017		<1%	4,617	$135K
41010		<1%	81	$133K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	2,958	$133K
77334		<1%	650	$132K
P9021	Red blood cells, each unit	<1%	515	$129K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	114	$128K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,936	$127K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	3,272	$127K
88142		<1%	4,898	$127K
D0150	Comprehensive oral evaluation - new or established patient	<1%	4,036	$125K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	9,029	$124K
97010		<1%	4,581	$124K
J9070	Cyclophosphamide, 100 mg	<1%	463	$124K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,625	$124K
77014		<1%	1,505	$122K
88112		<1%	916	$119K
97161		<1%	983	$119K
93296		<1%	3,837	$118K
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	128	$118K
97162		<1%	922	$118K
45390		<1%	90	$114K
88304		<1%	4,123	$114K
10060		<1%	392	$111K
90670		<1%	9,715	$109K
D0272	Bitewings - two radiographic images	<1%	9,269	$108K
90651		<1%	3,618	$108K
D1351	Sealant - per tooth	<1%	2,403	$105K
20610		<1%	148	$104K
76536		<1%	1,526	$103K
99381		<1%	752	$102K
97014		<1%	4,045	$98K
70491		<1%	638	$97K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	299	$97K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	2,914	$94K
99443		<1%	1,019	$93K
94728		<1%	430	$92K
76827		<1%	1,579	$92K
90647		<1%	8,896	$91K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	6,965	$88K
83655		<1%	5,669	$87K
54150		<1%	50	$87K
84443	Thyroid stimulating hormone (TSH)	<1%	17,619	$86K
99442		<1%	1,134	$85K
96411		<1%	1,707	$84K
96402		<1%	2,116	$83K
90723		<1%	9,028	$83K
93242		<1%	606	$82K
76937		<1%	519	$79K
85730		<1%	25,480	$78K
D0140	Limited oral evaluation - problem focused	<1%	4,053	$75K
82728		<1%	8,536	$74K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	667	$73K
87653		<1%	1,992	$71K
13132		<1%	105	$71K
76098		<1%	358	$69K
70544		<1%	283	$68K
J1756	Injection, iron sucrose, 1 mg	<1%	1,664	$68K
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	5,767	$67K
A9505	Thallium tl-201 thallous chloride, diagnostic, per millicurie	<1%	1,389	$67K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	23,425	$67K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	55	$67K
70486		<1%	1,569	$66K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	62	$66K
J7300	Intrauterine copper contraceptive (paragard)	<1%	79	$66K
77300		<1%	307	$65K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,104	$65K
97124		<1%	2,768	$64K
97163		<1%	530	$63K
76870		<1%	1,002	$63K
90633		<1%	5,317	$60K
93971		<1%	850	$60K
49500		<1%	26	$60K
90837	Psychotherapy session, about an hour	<1%	246	$59K
25600		<1%	131	$59K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	782	$58K
D0330	Panoramic radiographic image	<1%	2,262	$57K
83036	Hemoglobin; glycosylated (A1C)	<1%	13,570	$56K
94760		<1%	12,250	$54K
87481		<1%	1,854	$53K
94060		<1%	1,383	$53K
92526		<1%	431	$52K
84466		<1%	6,656	$52K
90681		<1%	5,859	$52K
84439		<1%	9,816	$52K
13152		<1%	85	$52K
94729		<1%	1,315	$51K
G0009	Administration of pneumococcal vaccine	<1%	4,892	$50K
97803		<1%	1,218	$49K
84133		<1%	22,809	$49K
95816		<1%	175	$49K
86923		<1%	980	$48K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	188	$48K
94726		<1%	1,340	$48K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,261	$48K
81015		<1%	14,439	$47K
76885		<1%	620	$47K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	2,095	$46K
41115		<1%	26	$46K
87086	Culture, bacterial; quantitative colony count, urine	<1%	16,898	$45K
70496		<1%	268	$45K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	2,193	$45K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	33	$45K
90620		<1%	2,620	$45K
D0220	Intraoral - periapical first radiographic image	<1%	6,064	$45K
90707		<1%	3,381	$44K
3E0234Z		<1%	105	$43K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	3,930	$42K
90746		<1%	856	$42K
81513		<1%	542	$42K
86780		<1%	7,125	$41K
82607		<1%	4,769	$41K
A0429	Emergency ambulance ride, basic life support	<1%	181	$41K
J7050	Infusion, normal saline solution, 250 cc	<1%	5,902	$41K
J9267	Injection, paclitaxel, 1 mg	<1%	2,079	$41K
90677		<1%	1,802	$40K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,033	$40K
90716		<1%	3,185	$39K
86803		<1%	5,557	$38K
83970		<1%	879	$38K
36561		<1%	29	$38K
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	30	$37K
85027		<1%	10,533	$36K
A4606	Oxygen probe for use with oximeter device, replacement	<1%	3,023	$36K
88360		<1%	309	$35K
82378		<1%	2,933	$35K
76882		<1%	933	$35K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,863	$34K
19085		<1%	13	$34K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	849	$34K
97116		<1%	1,268	$34K
C1726	Catheter, balloon dilatation, non-vascular	<1%	3,234	$33K
D0274	Bitewings - four radiographic images	<1%	1,801	$33K
96409		<1%	327	$32K
85004		<1%	36,804	$32K
99417	Prolong home eval add 15m	<1%	1,309	$31K
71045	Radiologic examination, chest; single view	<1%	10,329	$31K
82670		<1%	1,411	$31K
84484		<1%	16,506	$30K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	250	$30K
84702		<1%	10,196	$29K
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	<1%	492	$29K
90734		<1%	3,220	$29K
96523		<1%	598	$28K
97802		<1%	532	$28K
93351		<1%	170	$28K
83540		<1%	6,760	$28K
84403		<1%	1,343	$28K
83001		<1%	1,878	$27K
82784		<1%	2,376	$27K
83615		<1%	8,828	$27K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	8,027	$27K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	2,406	$27K
36410		<1%	1,307	$27K
D3220	Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction	<1%	249	$26K
92610		<1%	186	$26K
82746		<1%	3,203	$26K
D0230	Intraoral - periapical each additional radiographic image	<1%	1,892	$26K
83002		<1%	1,763	$25K
87340		<1%	5,626	$25K
J7030	Infusion, normal saline solution , 1000 cc	<1%	6,590	$25K
82248		<1%	6,715	$25K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	220	$24K
86300		<1%	1,510	$24K
D0210	Intraoral - complete series of radiographic images	<1%	1,457	$24K
81002		<1%	8,031	$24K
D8660		<1%	833	$24K
13131		<1%	40	$24K
77072		<1%	1,684	$23K
J9045	Injection, carboplatin, 50 mg	<1%	1,271	$23K
83020		<1%	2,514	$23K
90700		<1%	2,656	$23K
86880		<1%	1,111	$23K
86920		<1%	435	$23K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	119	$23K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	553	$22K
D9310		<1%	672	$22K
93321		<1%	2,210	$22K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	1,917	$22K
36406		<1%	815	$22K
72125	Computed tomography, cervical spine; without contrast material	<1%	985	$22K
76775		<1%	456	$22K
74220		<1%	490	$22K
93225		<1%	240	$21K
83735		<1%	12,676	$21K
86304		<1%	1,722	$21K
99441		<1%	329	$21K
93925		<1%	61	$20K
12052		<1%	29	$20K
87641		<1%	769	$20K
96401		<1%	239	$20K
99406		<1%	1,028	$19K
90696		<1%	2,146	$19K
19499		<1%	13	$19K
90378		<1%	173	$19K
84703		<1%	6,345	$19K
J9190	Injection, fluorouracil, 500 mg	<1%	1,687	$19K
86762		<1%	2,041	$19K
83921		<1%	1,349	$19K
76857		<1%	661	$19K
90656		<1%	1,724	$19K
74174		<1%	220	$19K
84146		<1%	1,178	$18K
84153		<1%	1,741	$18K
C1769	Guide wire	<1%	2,404	$17K
88321		<1%	227	$17K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	538	$17K
90710		<1%	2,041	$16K
93280		<1%	1,235	$16K
C1781	Mesh (implantable)	<1%	340	$16K
95812		<1%	58	$16K
58300		<1%	130	$16K
95807		<1%	40	$15K
12013		<1%	42	$15K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	37	$15K
86706		<1%	2,464	$15K
70498		<1%	247	$15K
D0340		<1%	292	$14K
83520		<1%	1,498	$14K
86301		<1%	1,005	$14K
83516		<1%	1,044	$14K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	3,905	$14K
75574		<1%	102	$14K
87070		<1%	4,419	$14K
12051		<1%	28	$14K
J0401	Injection, aripiprazole (abilify maintena), 1 mg	<1%	12	$14K
86140		<1%	7,254	$13K
D8080	Comprehensive orthodontic treatment of the adolescent dentition	<1%	15	$13K
D1354		<1%	795	$13K
C1889	Implantable/insertable device, not otherwise classified	<1%	159	$13K
43242		<1%	12	$13K
G0010	Administration of hepatitis b vaccine	<1%	856	$13K
74018		<1%	2,595	$12K
86704		<1%	2,166	$12K
73562		<1%	1,904	$12K
77295		<1%	58	$12K
92567		<1%	348	$12K
J3489	Injection, zoledronic acid, 1 mg	<1%	183	$12K
84402		<1%	573	$12K
73130		<1%	2,024	$11K
86376		<1%	1,036	$11K
74240		<1%	79	$11K
73610		<1%	2,023	$11K
62270		<1%	19	$11K
78306		<1%	54	$11K
73110		<1%	2,008	$10K
97164		<1%	198	$10K
88300		<1%	1,022	$10K
73630		<1%	1,990	$10K
84100		<1%	9,011	$10K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	12	$10K
96368		<1%	722	$10K
72100		<1%	692	$10K
82805		<1%	1,902	$10K
25605		<1%	24	$10K
99383		<1%	84	$10K
54300		<1%	80	$10K
95806		<1%	178	$9K
59840		<1%	13	$9K
82627		<1%	489	$9K
82565		<1%	2,095	$9K
Q5101	Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram	<1%	53	$9K
72141		<1%	37	$9K
85044		<1%	6,485	$9K
10005		<1%	13	$9K
73030		<1%	1,555	$8K
84305		<1%	574	$8K
A4648	Tissue marker, implantable, any type, each	<1%	476	$8K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	14,562	$8K
B4083	Stomach tube - levine type	<1%	1,055	$8K
24640		<1%	25	$8K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	576	$8K
86787		<1%	1,253	$8K
57425		<1%	12	$8K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	67	$7K
81001		<1%	7,776	$7K
87507		<1%	56	$7K
87184		<1%	3,420	$7K
88173		<1%	310	$7K
84481		<1%	2,031	$7K
82947		<1%	1,820	$7K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	116	$7K
76604		<1%	99	$7K
73560		<1%	646	$7K
72170		<1%	1,157	$7K
74178		<1%	25	$7K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	136	$7K
J2704	Injection, propofol, 10 mg	<1%	23,490	$7K
D1206	Topical application of fluoride varnish	<1%	391	$7K
85651		<1%	6,029	$6K
84480		<1%	1,175	$6K
90732		<1%	92	$6K
C1760	Closure device, vascular (implantable/insertable)	<1%	192	$6K
82977		<1%	1,775	$6K
26720		<1%	12	$6K
87634		<1%	682	$6K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	38	$6K
82043		<1%	1,636	$6K
D9430		<1%	302	$6K
73590		<1%	1,851	$6K
76830	Ultrasound, transvaginal	<1%	47	$6K
73620		<1%	833	$6K
D2335		<1%	29	$6K
93299		<1%	509	$6K
69210		<1%	36	$6K
73120		<1%	635	$6K
93246		<1%	37	$6K
86038		<1%	1,221	$5K
D2330		<1%	54	$5K
D9230	Inhalation of nitrous oxide / analgesia, anxiolysis	<1%	180	$5K
01967	Neuraxial labor analgesia/anesthesia for planned vaginal delivery	<1%	12	$5K
86360		<1%	163	$5K
93298		<1%	200	$5K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	13,221	$5K
A0425	Ground mileage, per statute mile	<1%	633	$5K
J3490	Unclassified drugs	<1%	2,457	$5K
83030		<1%	1,427	$5K
82570		<1%	2,015	$5K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,807	$5K
90849		<1%	65	$5K
84165		<1%	957	$5K
88108		<1%	64	$5K
85240		<1%	359	$5K
86256		<1%	584	$5K
83519		<1%	501	$5K
71271		<1%	79	$5K
90662		<1%	228	$5K
97168		<1%	82	$5K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	1,275	$5K
92587		<1%	56	$5K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	536	$4K
73090		<1%	2,056	$4K
86359		<1%	163	$4K
80320		<1%	2,692	$4K
93978		<1%	12	$4K
77332		<1%	43	$4K
84156		<1%	2,029	$4K
73080		<1%	1,592	$4K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	854	$4K
97165		<1%	41	$4K
82652		<1%	266	$4K
0072A		<1%	78	$4K
82105		<1%	690	$4K
83690		<1%	16,473	$4K
84550		<1%	2,041	$4K
86160		<1%	350	$4K
87536		<1%	78	$4K
73600		<1%	629	$4K
86665		<1%	455	$4K
85379		<1%	2,668	$4K
85245		<1%	179	$4K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	607	$4K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	6,236	$3K
84436		<1%	1,293	$3K
0071A		<1%	110	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,211	$3K
86696		<1%	185	$3K
81003		<1%	4,649	$3K
D0350		<1%	273	$3K
90743		<1%	87	$3K
96377		<1%	173	$3K
73502		<1%	418	$3K
80069		<1%	380	$3K
86695		<1%	180	$3K
J9171	Injection, docetaxel, 1 mg	<1%	20	$3K
86870		<1%	140	$3K
0002A		<1%	188	$3K
10061		<1%	12	$3K
92523		<1%	13	$3K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	12	$3K
77280		<1%	14	$3K
82533		<1%	208	$3K
Q3014	Telehealth originating site facility fee	<1%	360	$3K
86664		<1%	455	$3K
51701		<1%	12	$3K
85246		<1%	165	$3K
A4627	Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler	<1%	177	$3K
74230		<1%	30	$3K
87040		<1%	4,202	$2K
74181		<1%	12	$2K
D2331		<1%	27	$2K
C1874	Stent, coated/covered, with delivery system	<1%	25	$2K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	307	$2K
0001A		<1%	172	$2K
84144		<1%	115	$2K
86225		<1%	447	$2K
86255		<1%	370	$2K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,053	$2K
86800		<1%	225	$2K
73552		<1%	536	$2K
96376		<1%	2,634	$2K
73060		<1%	889	$2K
76801		<1%	14	$2K
82550		<1%	1,895	$2K
73700		<1%	12	$2K
99152		<1%	1,198	$2K
93282		<1%	26	$2K
C1758	Catheter, ureteral	<1%	715	$2K
87563		<1%	65	$2K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,177	$2K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	45	$1K
85250		<1%	31	$1K
90688		<1%	233	$1K
83883		<1%	173	$1K
97035		<1%	143	$1K
29125		<1%	12	$1K
82247		<1%	355	$1K
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	208	$1K
S0028	Injection, famotidine, 20 mg	<1%	3,040	$1K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	5,571	$1K
90675		<1%	28	$1K
96167		<1%	12	$1K
85045		<1%	1,225	$1K
86707		<1%	196	$1K
82150		<1%	755	$1K
77417		<1%	133	$1K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	10,008	$1K
92555		<1%	35	$1K
76813		<1%	14	$1K
0296T		<1%	12	$1K
99384		<1%	14	$1K
83498		<1%	52	$1K
87517		<1%	27	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	19,950	$1K
86708		<1%	166	$1K
92588		<1%	13	$1K
86235		<1%	89	$1K
88720		<1%	283	$992.06
92611		<1%	12	$972.08
76376		<1%	138	$969.52
85280		<1%	40	$904.73
73140		<1%	98	$875.52
0003A		<1%	21	$870.36
73100		<1%	58	$862.06
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	10,255	$824.68
99354		<1%	17	$800.93
80164		<1%	315	$759.43
88311		<1%	51	$758.29
70360		<1%	157	$741.44
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,137	$736.87
J2270	Injection, morphine sulfate, up to 10 mg	<1%	9,025	$734.48
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,757	$719.04
72082		<1%	27	$708.36
J0280	Injection, aminophyllin, up to 250 mg	<1%	275	$654.68
97018		<1%	235	$640.13
80329		<1%	1,389	$628.91
J9206	Injection, irinotecan, 20 mg	<1%	27	$617.03
82157		<1%	26	$606.97
86431		<1%	183	$606.53
A4614	Peak expiratory flow rate meter, hand held	<1%	61	$605.74
87075		<1%	342	$605.26
81404		<1%	28	$586.60
A7015	Aerosol mask, used with dme nebulizer	<1%	139	$577.26
86922		<1%	18	$564.89
90671		<1%	33	$527.17
99153	Mod sedat endo service >5yrs	<1%	571	$503.55
J9370	Vincristine sulfate, 1 mg	<1%	60	$501.67
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	20	$500.60
83993		<1%	44	$499.62
84145		<1%	474	$455.41
D0470		<1%	13	$442.00
86580		<1%	56	$440.50
85384		<1%	195	$429.84
C1788	Port, indwelling (implantable)	<1%	17	$422.80
J0694	Injection, cefoxitin sodium, 1 gm	<1%	937	$421.88
87493		<1%	12	$420.23
A7016	Dome and mouthpiece, used with small volume ultrasonic nebulizer	<1%	128	$410.90
J3480	Injection, potassium chloride, per 2 meq	<1%	699	$389.85
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	23,507	$380.12
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	12	$379.56
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,981	$365.91
88333		<1%	12	$355.53
90473		<1%	46	$347.50
87420		<1%	57	$346.08
87102		<1%	66	$342.34
90744		<1%	42	$336.89
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	28	$335.42
99024		<1%	927	$330.08
87205		<1%	368	$321.93
Q9962	High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml	<1%	100	$309.60
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,790	$306.44
90672		<1%	61	$304.52
94618		<1%	26	$293.49
85613		<1%	65	$290.31
80178		<1%	151	$277.19
74019		<1%	150	$264.31
D0270		<1%	38	$261.53
85270		<1%	13	$245.02
82785		<1%	25	$241.99
80050	General health panel	<1%	12	$240.82
90685		<1%	103	$214.20
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	13	$209.46
73000		<1%	25	$195.53
87338		<1%	31	$192.45
86709		<1%	41	$182.76
73070		<1%	73	$177.42
87116		<1%	55	$170.69
91307		<1%	215	$168.73
86618		<1%	14	$168.26
81005		<1%	165	$165.05
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	308	$159.65
82948		<1%	2,454	$159.46
84520		<1%	39	$157.97
A4649	Surgical supply; miscellaneous	<1%	1,618	$153.82
90381		<1%	15	$150.68
72040		<1%	13	$150.15
86334		<1%	12	$138.51
86765		<1%	12	$128.03
82272		<1%	53	$123.87
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	519	$123.21
94761		<1%	30	$122.52
88302		<1%	30	$116.06
86694		<1%	12	$115.33
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	610	$111.67
J1631	Injection, haloperidol decanoate, per 50 mg	<1%	81	$97.95
C9113	Injection, pantoprazole sodium, per vial	<1%	91	$89.60
82985		<1%	12	$78.86
J3370	Injection, vancomycin hcl, 500 mg	<1%	203	$70.81
87206		<1%	41	$69.35
72070		<1%	15	$65.38
87350		<1%	14	$61.34
87045		<1%	24	$59.46
A4570	Splint	<1%	560	$58.62
92579		<1%	13	$54.20
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,830	$51.57
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	2,733	$50.90
83550		<1%	12	$40.64
86593		<1%	14	$39.10
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	120	$35.90
87177		<1%	12	$35.60
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	990	$29.54
J1790	Injection, droperidol, up to 5 mg	<1%	208	$28.76
93284		<1%	13	$28.69
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	1,745	$27.83
89051		<1%	28	$25.20
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	178	$24.85
J7510	Prednisolone oral, per 5 mg	<1%	100	$21.23
J1940	Injection, furosemide, up to 20 mg	<1%	45	$18.98
A6455	Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard	<1%	192	$17.14
J7999	Compounded drug, not otherwise classified	<1%	137	$16.00
80156		<1%	12	$14.57
J1170	Injection, hydromorphone, up to 4 mg	<1%	55	$12.07
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	825	$9.53
Q9960	High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml	<1%	659	$8.72
A4616	Tubing (oxygen), per foot	<1%	111	$8.43
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	341	$8.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	74	$7.84
82010		<1%	131	$7.68
J2060	Injection, lorazepam, 2 mg	<1%	277	$7.58
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	283	$7.42
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,347	$6.44
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	164	$6.44
J2599	Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit	<1%	12	$5.80
91300		<1%	289	$3.96
86710		<1%	79	$2.38
J1836	Injection, metronidazole, 10 mg	<1%	156	$0.13
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	92	$0.06
99080		0%	2,563	$0.00
S0030	Injection, metronidazole, 500 mg	0%	69	$0.00
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	0%	53	$0.00
99499		0%	14	$0.00
L8613	Ossicula implant	0%	14	$0.00
82140		0%	15	$0.00
A4590	Special casting material (e.g., fiberglass)	0%	30	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	305	$0.00
99429		0%	490	$0.00
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	0%	56	$0.00
Q4050	Cast supplies, for unlisted types and materials of casts	0%	14	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	71	$0.00
C9399	Unclassified drugs or biologicals	0%	92	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	52	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKOBUS, KAREN (VICE PRESIDENT,PROFESSIONAL AFFAIRS)